A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaMaria Domenica Cappellini, Antonio Piga, Vip Viprakasit et al.|New England Journal of Medicine|2020Cited by 320
Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell diseaseErsi Voskaridou, Dimitris Loukopoulos, Maroussa Douskou et al.|British Journal of Haematology|2004Cited by 148
Early markers of renal dysfunction in patients with sickle cell/β-thalassemiaErsi Voskaridou, Ioannis Papassotiriou, Evangelos Terpos et al.|Kidney International|2006Cited by 76
National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortalityIoannis Papassotiriou, Konstantina Nestora, Ioanna Tzoumari et al.|Annals of Hematology|2018Cited by 72
Osteoporosis and osteosclerosis in sickle cell/beta-thalassemia: the role of the RANKL/osteoprotegerin axis.Ersi Voskaridou, Evangelos Terpos, Eleni Stoupa et al.|PubMed|2006Cited by 62